Recursos del Paciente
Manténgase sano!
Resultados de su búsqueda "Weight Loss".
04 Sep
Taking Ozempic or Wegovy Does Not Increase Risk for Mental Health Issues, Study Finds
Researchers find no link between semaglutide, the main ingredient in Ozempic and Wegovy, and depression, suicidal thoughts or behaviors in patients with no prior history of the conditions.
Resultados de noticias de salud - 173
Ozempic, Wegovy Could Help Ease Knee Arthritis Pain
- Dennis Thompson HealthDay Reporter
- November 1, 2024
- Página completa
The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.
People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% dec...
Ozempic Curbs Kidney Disease in Obese People Without Diabetes
- Dennis Thompson HealthDay Reporter
- October 28, 2024
- Página completa
The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.
Patients taking semaglutide -- the active agent in Ozempic and Wegovy -- had as ...
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
- Ernie Mundell HealthDay Reporter
- October 25, 2024
- Página completa
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and...
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
- Dennis Thompson HealthDay Reporter
- October 24, 2024
- Página completa
Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.
People with type 2 diabetes taking semaglutide appeared to have a significantly...
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
- Dennis Thompson HealthDay Reporter
- October 24, 2024
- Página completa
Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year...
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
- Robin Foster HealthDay Reporter
- October 15, 2024
- Página completa
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.
GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It
- October 14, 2024
- Página completa
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.
But a new study involving more than 54,000 U.S. adolescents found no such...
Ozempic Plus Intestinal 'Zap' Therapy May Eliminate Need for Insulin in Type 2 Diabetics
- Ernie Mundell HealthDay Reporter
- October 14, 2024
- Página completa
Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes.
The new trial hasn't yet been published in a peer-reviewed journal and...
Could Certain Genes Help You Slim Down?
- Dennis Thompson HealthDay Reporter
- October 11, 2024
- Página completa
The key to weight loss could come down to a combination of 14 “skinny genes,” a recent study says.
People with these genes dropped twice as much weight through regular exercise compared to those without the genes, researchers found.
Those with the most ...
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees
- Robin Foster HealthDay Reporter
- October 9, 2024
- Página completa
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows.
GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy
- Ernie Mundell HealthDay Reporter
- October 1, 2024
- Página completa
Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.
Now, research finds this scenario is more lik...
Could Ozempic Help Prevent Opioid Overdoses?
- Dennis Thompson HealthDay Reporter
- September 25, 2024
- Página completa
In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose.
...
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
- Robin Foster HealthDay Reporter
- September 25, 2024
- Página completa
During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its block...
Endurance Exercise Can Get Rid of Body Fat, Even Without Weight Loss
- Dennis Thompson HealthDay Reporter
- September 20, 2024
- Página completa
Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates.
A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because they ate and dr...
Cost Has Many Going Around Doctors to Get Weight-Loss Meds
- Dennis Thompson HealthDay Reporter
- September 18, 2024
- Página completa
Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.
They’re in short supply, and often too expensive to afford without insurance cover...
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease
- Ernie Mundell HealthDay Reporter
- September 16, 2024
- Página completa
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
In a new decades-long study, veterans with diabetes...
Ozempic or Saxenda for Weight Loss: Which Works Best?
- Dennis Thompson HealthDay Reporter
- September 13, 2024
- Página completa
Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds.<...
Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight
- Dennis Thompson HealthDay Reporter
- September 13, 2024
- Página completa
Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a n...
In Every U.S. State, at Least 1 in 5 People Is Now Obese
- Ernie Mundell HealthDay Reporter
- September 12, 2024
- Página completa
Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows.
In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distin...
Weight-Loss Drug Zepbound May Work Better in Women Than Men
- Dennis Thompson HealthDay Reporter
- September 12, 2024
- Página completa
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval.
All doses of tirzepatide consistently reduced weight in...
Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues
- Dennis Thompson HealthDay Reporter
- September 12, 2024
- Página completa
Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.
The drugs’ a...
Weight-Loss Pill Saxenda Helps Kids as Young as 6
- Robin Foster HealthDay Reporter
- September 11, 2024
- Página completa
The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report.
The findings, published Tuesday in the New England Journal of Medicine and...
Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug
- Dennis Thompson HealthDay Reporter
- September 11, 2024
- Página completa
An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.
People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for th...
.jpg?w=1920&h=1080&mode=crop&crop=focalpoint)
Obesity Raises Risk of Severe Infection, Especially in People With Diabetes
- Ernie Mundell HealthDay Reporter
- September 9, 2024
- Página completa
Losing weight can help a person with obesity -- especially those with diabetes -- fend off serious infections, new data shows.
It's an important finding, since "up to one in three hospitalizations in people with diabetes are for infections and people with diabetes are tw...
Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection
- Dennis Thompson HealthDay Reporter
- September 9, 2024
- Página completa
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates.
...
Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds
- Dennis Thompson HealthDay Reporter
- September 3, 2024
- Página completa
The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or
Taking Wegovy, Zepbound? One Expert Has Dietary Advice
- Dennis Thompson HealthDay Reporter
- September 3, 2024
- Página completa
Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health.
But they sti...
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find
- Ernie Mundell HealthDay Reporter
- August 30, 2024
- Página completa
New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
These two injected drugs are versions of semaglutide. In multiple new data analyses, the d...
.jpg?w=1920&h=1080&mode=crop&crop=focalpoint)
Why Breast Feeding May Be Even Healthier for Heavier New Moms
- Ernie Mundell HealthDay Reporter
- August 29, 2024
- Página completa
Breastfeeding helps women shed those extra pounds of "pregnancy weight," a new study finds, and the effect is even more pronounced for moms who were overweight before their pregnancy.
Among women who exclusively breastfed their baby during its first year, women who were...
3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules
- Dennis Thompson HealthDay Reporter
- August 27, 2024
- Página completa
New Medicare rules could make 3.6 million Americans -- or even more -- eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds.
Under the new rules, the...
.jpeg?w=1920&h=1080&mode=crop&crop=focalpoint)
Getting Fats From Plants Vs. Animals Boosts Your Life Span
- Ernie Mundell HealthDay Reporter
- August 12, 2024
- Página completa
A study of more than 400,000 people tracked for up to 24 years finds that those who got their dietary fat from plants versus animals had significantly lower odds of dying during the study period.
Plant-based fats' benefit included a reduced odds for deaths due to heart d...
Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds
- Dennis Thompson HealthDay Reporter
- August 7, 2024
- Página completa
WEDNESDAY, Aug. 7, 2024 (HealthDay news) -- Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds.
Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger
- Ernie Mundell HealthDay Reporter
- August 2, 2024
- Página completa
Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug.
One study ...
Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic
- Dennis Thompson HealthDay Reporter
- July 23, 2024
- Página completa
The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds.&...
Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle
- Dennis Thompson HealthDay Reporter
- July 12, 2024
- Página completa
Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person's lifestyle, a new study says.
Cigarette smoking remains the biggest cancer risk, contributing to 30% of cancer deaths and 20% of cancer cases, results show.
But excess body weight, dri...
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
- Robin Foster HealthDay Reporter
- July 11, 2024
- Página completa
Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.
Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the
Mounjaro Bests Ozempic for Weight Loss
- Dennis Thompson HealthDay Reporter
- July 8, 2024
- Página completa
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows.
People taking tirzepatide (Mounjaro, Zepbound)...
Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers
- Robin Foster HealthDay Reporter
- July 8, 2024
- Página completa
In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers.
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
- Dennis Thompson HealthDay Reporter
- July 2, 2024
- Página completa
Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.
People taking semaglutide had 50% to 56% decreased odds for either becoming alcoholic or relapsing into alcoholism, researchers reported recently in the journal
Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms
- Dennis Thompson HealthDay Reporter
- June 25, 2024
- Página completa
Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows.
Both men and women showed improved heart function after a year on
Healthy Weight Loss Could Lower Your Odds for Cancer
- Dennis Thompson HealthDay Reporter
- June 25, 2024
- Página completa
Losing weight can protect you against cancers related to obesity, a new study finds.
Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.
But study resul...
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea
- Carole Tanzer Miller HealthDay Reporter
- June 21, 2024
- Página completa
A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.
The worldwide clinical trial demonstrates that tirzepatide significantly lowers breathing interruptions during sleep, a key ...
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
- Robin Foster HealthDay Reporter
- June 21, 2024
- Página completa
Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.
Looking for Weight Loss? Go Nuts
- Dennis Thompson HealthDay Reporter
- June 20, 2024
- Página completa
Folks dieting to drop pounds should consider eating a fistful of nuts here and there, a new review suggests.
People who ate 1.5 to 3 ounces of almonds, peanuts, pistachios or walnuts daily as part of a calorie-cutting
Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat
- Dennis Thompson HealthDay Reporter
- June 11, 2024
- Página completa
Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional req...
Wegovy, Ozempic May Help Curb Alcohol Dependence
- Ernie Mundell HealthDay Reporter
- June 4, 2024
- Página completa
Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.
Researchers at Case Western...
Could New Weight-Loss Drugs Be Changing Women's Taste for Sweets?
- Dennis Thompson HealthDay Reporter
- June 3, 2024
- Página completa
Ozempic and Wegovy appear to improve people's sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests.
The active ingredient in the weight-loss ...
GLP-1 Weight Loss Meds Might Keep Your Pancreas Healthy
- Dennis Thompson HealthDay Reporter
- June 3, 2024
- Página completa
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says.
Up to now, doctors have been cautious about prescribing se...
Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds
- Ernie Mundell HealthDay Reporter
- May 23, 2024
- Página completa
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows.
Reasons for quitting Wegovy, Ozempic or similar drugs m...
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans
- Ernie Mundell HealthDay Reporter
- May 22, 2024
- Página completa
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.
That's compared to an overall decline of about 3% in young Americans' use of other types of pre...